AU2003290012A1 - L2-peptide of the human papillomavirus associated with virus-like particles - Google Patents

L2-peptide of the human papillomavirus associated with virus-like particles

Info

Publication number: AU2003290012A1
Authority: AU; Australia
Prior art keywords: virus; peptide; particles; human papillomavirus; papillomavirus associated
Prior art date: 2002-12-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003290012A

Inventor

Ralph Biemans

Brigitte Desiree Alberte Colau

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GlaxoSmithKline Biologicals SA

Original Assignee

GlaxoSmithKline Biologicals SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-09

Filing date

2003-12-05

Publication date

2004-06-30

2003-12-05 Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA

2004-06-30 Publication of AU2003290012A1 publication Critical patent/AU2003290012A1/en

Status Abandoned legal-status Critical Current

Links

241000701806 Human papillomavirus Species 0.000 title 1
239000002245 particle Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]

AU2003290012A 2002-12-09 2003-12-05 L2-peptide of the human papillomavirus associated with virus-like particles Abandoned AU2003290012A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0228715A GB0228715D0 (en)	2002-12-09	2002-12-09	Vaccine
GB0228715.9		2002-12-09
PCT/EP2003/014040 WO2004052395A1 (en)	2002-12-09	2003-12-05	L2-peptide of the human papillomavirus associated with virus-like particles

Publications (1)

Publication Number	Publication Date
AU2003290012A1 true AU2003290012A1 (en)	2004-06-30

Family

ID=9949366

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003290012A Abandoned AU2003290012A1 (en)	2002-12-09	2003-12-05	L2-peptide of the human papillomavirus associated with virus-like particles

Country Status (3)

Country	Link
AU (1)	AU2003290012A1 (en)
GB (1)	GB0228715D0 (en)
WO (1)	WO2004052395A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006113209A1 (en)	2005-04-15	2006-10-26	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
US8466259B2 (en)	2007-12-07	2013-06-18	National Health Research Institutes	Adjuvants
TWI376385B (en)	2007-12-07	2012-11-11	Nat Health Research Institutes	Production of lipidated proteins in e. coli
US8287880B2 (en)	2009-06-02	2012-10-16	National Health Research Institutes	Lipidated vaccine against dengue virus infection
EP2445927B1 (en)	2009-06-22	2014-04-23	National Health Research Institutes	Lipidated tumor- associated antigens and immunotherapeutic compositions
MA33440B1 (en)	2009-06-25	2012-07-03	Glaxosmithkline Biolog Sa	New combinations
US9717783B2 (en)	2010-02-09	2017-08-01	Stc.Unm	Immunogenic HPV L2-containing VLPs and related compositions, constructs, and therapeutic methods
TWI507413B (en) *	2010-11-15	2015-11-11	Nat Health Research Institutes	Lipidated polyepitope vaccines
TW201221642A (en)	2010-11-15	2012-06-01	Nat Health Research Institutes	Method of producing lipidated polypeptides
MA40824A (en)	2014-10-22	2017-08-29	Saiba Gmbh	MODIFIED VIRUS TYPE CMV PARTICLES
CA2994353A1 (en) *	2015-09-08	2017-03-16	Universitat Zurich	Treatment of insect bite hypersensitivity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5618536A (en) *	1992-09-03	1997-04-08	The United States Of America As Represented By The Department Of Health And Human Services	Chimeric papillomavirus-like particles
FR2749323B1 (en) *	1996-06-04	1998-07-10	Pasteur Merieux Serums Vacc	PSEUDO-PARTICLES VIRALES USEFUL AS A VECTOR OF NUCLEIC ACID DELIVERY
GB9806666D0 (en) *	1998-03-27	1998-05-27	Stanley Margaret	Antigen preparation and use
WO2003097673A2 (en) *	2002-05-17	2003-11-27	University Of Cape Town	Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles.

2002
- 2002-12-09 GB GB0228715A patent/GB0228715D0/en not_active Ceased
2003
- 2003-12-05 AU AU2003290012A patent/AU2003290012A1/en not_active Abandoned
- 2003-12-05 WO PCT/EP2003/014040 patent/WO2004052395A1/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB0228715D0 (en)	2003-01-15
WO2004052395A1 (en)	2004-06-24

Legal Events

Date	Code	Title	Description
2005-08-25	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Publication	Publication Date	Title
AP2004003136A0 (en)	2004-09-30	Virus-like particles of human papillomavirus
AU2003213606A1 (en)	2003-10-13	MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003227533A1 (en)	2003-09-29	Virus like particle from papillomavirus and their use in vaccine
AU2003272187A1 (en)	2004-01-06	Novel nanoparticles and use thereof
AU2003248721A1 (en)	2004-01-06	Adsorbents, methods of preparation, and methods of use thereof
AU2003298998A1 (en)	2004-04-08	Oriented nanostructures and methods of preparing
AU2003293294A1 (en)	2004-04-19	Uv-stabilised particles
AU2003270626A1 (en)	2004-04-30	Magnetically modified electrodes as well as methods of making and using the same
AU2003232650A1 (en)	2004-11-26	N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
AU2003225756A1 (en)	2003-09-29	Silica-based materials and methods
AU2003262804A1 (en)	2004-03-11	Arginine silicate inositol complex and use thereof
AU2003231352A1 (en)	2003-12-19	Biocidal formulation and methods for the preparation thereof
AU2003218099A1 (en)	2003-09-29	Modulation of the immune response through the manipulation of arginine levels
AU2003290012A1 (en)	2004-06-30	L2-peptide of the human papillomavirus associated with virus-like particles
AU2003296369A1 (en)	2004-06-30	Imminoamines and preparation thereof
AU2003239610A1 (en)	2003-12-19	Tiled biochips and the methods of making the same
AU2003285320A1 (en)	2004-06-07	Vaccine
AU2003248879A1 (en)	2004-01-23	RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
AU2003297612A1 (en)	2004-06-23	2-substituted-3-propenamide derivatives and methods of using the same
GB0201382D0 (en)	2002-03-13	Virus-like particles
GB0200258D0 (en)	2002-02-20	Detection of human papillomavirus
AU2003278420A1 (en)	2004-05-25	Process for the preparation of ganciclovir
AU2002236065A1 (en)	2002-09-19	Papillomavirus vaccines
AU2003237701A1 (en)	2003-12-12	Vaccines
AU2003269257A1 (en)	2004-05-04	Use of cap-1 for the therapy of asthma